+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Benign Prostatic Hyperplasia (BPH) Devices Market 2024-2028 - Product Thumbnail Image

Benign Prostatic Hyperplasia (BPH) Devices Market 2024-2028

  • Report
  • October 2024
  • 139 Pages
  • Global
From
From
From
From
From
From
From
Anti-Infective Market Report and Forecast 2023-2031 - Product Thumbnail Image

Anti-Infective Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 140 Pages
  • Global
From
CAR-T Therapy Pipeline Analysis Global Market Report 2023 - Product Thumbnail Image

CAR-T Therapy Pipeline Analysis Global Market Report 2023

  • Report
  • February 2023
  • 175 Pages
  • Global
From
From
Gene Therapy-Competitive landscape, 2023 - Product Thumbnail Image

Gene Therapy-Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
From
From
Antifungal Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Antifungal Drugs Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Japan - Healthcare, Regulatory and Reimbursement Landscape - Product Thumbnail Image

Japan - Healthcare, Regulatory and Reimbursement Landscape

  • Report
  • April 2021
  • 167 Pages
  • Japan
From
Loading Indicator